Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)-Reference-Cited by-同舟云学术

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

Published:2019-08 Issue:8 Volume:21 Page:1990-1995
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Koshizaka Masaya¹²,Ishikawa Ko¹²,Ishibashi Ryoichi²³^ORCID,Maezawa Yoshiro¹²,Sakamoto Kenichi²,Uchida Daigaku⁴,Nakamura Susumu⁵,Yamaga Masaya⁶,Yokoh Hidetaka¹²,Kobayashi Akina¹²,Onishi Shunichiro⁷,Kobayashi Kazuki²⁷,Ogino Jun⁸,Hashimoto Naotake⁸,Tokuyama Hirotake⁹,Shimada Fumio¹⁰,Ohara Emi¹⁰,Ishikawa Takahiro¹¹¹,Shoji Mayumi¹²,Ide Shintaro¹²,Ide Kana¹²,Baba Yusuke¹²,Hattori Akiko¹²,Kitamoto Takumi¹²,Horikoshi Takuro¹²,Shimofusa Ryota¹³,Takahashi Sho¹⁴,Nagashima Kengo¹⁵^ORCID,Sato Yasunori¹⁵,Takemoto Minoru¹⁶,Newby Laura Kristin¹⁷,Yokote Koutaro¹²^ORCID,

Affiliation:

1. Department of Diabetes, Metabolism and EndocrinologyChiba University Hospital Chiba Japan

2. Department of Endocrinology, Hematology and GerontologyChiba University Graduate School of Medicine Chiba Japan

3. Division of Diabetes, Endocrinology and MetabolismKimitsu Chuo Hospital Chiba Japan

4. Department of Internal Medicine, Hotaruno Central Naika Chiba Japan

5. Department of Internal Medicine, Odayama Clinic Chiba Japan

6. Department of Diabetes and MetabolismJapanese Red Cross Narita Hospital Chiba Japan

7. Department of Diabetes and MetabolismAsahi General Hospital Chiba Japan

8. Department of Diabetes, Endocrine and Metabolic DiseasesTokyo Women's Medical University Yachiyo Medical Center Chiba Japan

9. Department of Internal Medicine, Yukarigaoka Tokuyama Medical Clinic Chiba Japan

10. Department of Diabetes and MetabolismNational Hospital Organization Chiba Medical Center Chiba Japan

11. Geriatric Medical CenterChiba University Hospital Chiba Japan

12. Diagnostic Radiology and Radiation OncologyChiba University Graduate School of Medicine Chiba Japan

13. Department of RadiologySannou Hospital Chiba Japan

14. Clinical Research CenterChiba University Hospital Chiba Japan

15. Department of Global Clinical ResearchChiba University, Graduate School of Medicine Chiba Japan

16. Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, Chiba, Japan

17. Duke Clinical Research InstituteDuke University Medical Center Durham North Carolina

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13750

Reference20 articles.

1. Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men

2. Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

3. Energy intake and obesity in Japanese patients with type 2 diabetes

4. Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

5. The Effects of Dipeptidyl Peptidase-4 Inhibitors in Treatment of Obese Patients with Type 2 Diabetes

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07-08

2. View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences;Pharmaceuticals;2024-04-08

3. Sodium–Glucose Cotransporter Protein 2 Inhibitors: Novel Application for the Treatment of Obesity-Associated Hypertension;Diabetes, Metabolic Syndrome and Obesity;2024-01

4. A systematic review of interventional trials on the effects of coconut derivatives on metabolic control in type 2 diabetes mellitus;AIP Conference Proceedings;2024

5. Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-10-12